BILL · 2021–22 SESSION
SB 5981: Cannabinoid products
Concerning cannabinoid products.
Did not pass Did not pass · died in committee
- IntroducedFeb 24, 2022
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Derek Stanford (D-1)
- Introduced
- February 24, 2022 in the Senate
- Last action
- February 24, 2022
- Companion bill
- HB 2123
AN ACT Relating to ensuring consumers have legal access to cannabinoid products that have been tested and that meet standards for quality and safety while preventing intoxicating products from being sold outside of the regulated adult-use cannabis market and establishing a scientific panel to review cannabinoid science;
Sponsors
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- First reading, referred to Labor, Commerce & Tribal Affairs.
SB 5981 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5981 (2025–26) 340B drug pricing program
- SB 5981 (2023–24) Early release petitions
- SB 5981 (2019–20) Greenhouse gas cap and trade
- SB 5981 (2017–18) Capital budget 2017-2019
- SB 5981 (2015–16) State debt limitations
- SB 5981 (2013–14) Mason Co. superior crt judge
- SB 5981 (2011–12) Seed dealer license fees
- SB 5981 (2009–10) Diagnostic imaging services